These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12050486

  • 1. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
    Pak CY, Peterson RD, Poindexter J.
    J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
    [Abstract] [Full Text] [Related]

  • 2. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 3. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR, Leitao VA, Haleblian GE, Scales CD, Chandrashekar A, Pierre SA, Preminger GM.
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [Abstract] [Full Text] [Related]

  • 4. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL, Steele TH, Nakada SY.
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [Abstract] [Full Text] [Related]

  • 5. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery.
    Sakhaee K, Griffith C, Pak CY.
    Surg Obes Relat Dis; 2012 Nov; 8(1):67-72. PubMed ID: 21703942
    [Abstract] [Full Text] [Related]

  • 6. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP, Penniston KL, Wolf JS, Nakada SY.
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [Abstract] [Full Text] [Related]

  • 7. Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia.
    Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R.
    J Am Soc Nephrol; 2006 Nov; 17(11):3213-22. PubMed ID: 17035614
    [Abstract] [Full Text] [Related]

  • 8. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 9. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG, Paquette EL, Cullen J, Gancarczyk KK, Tucciarone PR, Schenkman NS.
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [Abstract] [Full Text] [Related]

  • 10. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 11. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting.
    Nicar MJ, Hsu MC, Fetner C.
    Clin Ther; 1986 Jun; 8(2):219-25. PubMed ID: 3698069
    [Abstract] [Full Text] [Related]

  • 12. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K, Poindexter JR, Griffith CS, Pak CY.
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [Abstract] [Full Text] [Related]

  • 13. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
    Jiménez Verdejo A, Arrabal Martín M, Miján Ortiz JL, Hita Rosino E, Palao Yago F, Zuluaga Gómez A.
    Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm followup study.
    Lee YH, Huang WC, Tsai JY, Huang JK.
    J Urol; 1999 May; 161(5):1453-7. PubMed ID: 10210371
    [Abstract] [Full Text] [Related]

  • 15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P.
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [Abstract] [Full Text] [Related]

  • 16. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
    Jiang Y, Li M, Xia W, Xing X, Yu W, Tian J, Meng X, Zhou X.
    Zhonghua Yi Xue Za Zhi; 2002 Sep 25; 82(18):1254-6. PubMed ID: 12425805
    [Abstract] [Full Text] [Related]

  • 17. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
    Whitson PA, Pietrzyk RA, Jones JA, Nelman-Gonzalez M, Hudson EK, Sams CF.
    J Urol; 2009 Nov 25; 182(5):2490-6. PubMed ID: 19765769
    [Abstract] [Full Text] [Related]

  • 18. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W.
    Am J Kidney Dis; 2006 Oct 25; 48(4):546-54. PubMed ID: 16997050
    [Abstract] [Full Text] [Related]

  • 19. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
    Tapaneya-Olarn W, Khositseth S, Tapaneya-Olarn C, Teerakarnjana N, Chaichanajarernkul U, Stitchantrakul W, Petchthong T.
    J Med Assoc Thai; 2002 Nov 25; 85 Suppl 4():S1143-9. PubMed ID: 12549788
    [Abstract] [Full Text] [Related]

  • 20. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R, Taguchi K, Okada A, Ando R, Hamamoto S, Kubota Y, Zuo L, Tozawa K, Kohri K, Yasui T.
    Int J Urol; 2017 Jan 25; 24(1):75-81. PubMed ID: 27747937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.